Towards a molecular approach to gastric cancer management

Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring

1999 • 11,586 citations

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays

1999 • 4,195 citations

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1998 • 4,104 citations

Expression monitoring by hybridization to high-density oligonucleotide arrays

1996 • 2,796 citations

Functional Discovery via a Compendium of Expression Profiles

2000 • 2,581 citations

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

2000 • 2,355 citations

Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia

1991 • 2,278 citations

Systematic variation in gene expression patterns in human cancer cell lines

2000 • 2,119 citations

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

1998 • 2,080 citations

Use of a cDNA microarray to analyse gene expression patterns in human cancer

1996 • 2,002 citations

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

2000 • 1,770 citations

E-cadherin germline mutations in familial gastric cancer

1998 • 1,629 citations

Extended Lymph-Node Dissection for Gastric Cancer

1999 • 1,567 citations

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

2000 • 1,356 citations

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

2000 • 934 citations

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

2000 • 897 citations

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1997 • 875 citations

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

2000 • 601 citations

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

1993 • 560 citations

Tumor Suppressor Genes: The Puzzle and the Promise

1989 • 488 citations

Tissue microarrays for gene amplification surveys in many different tumor types.

1999 • 440 citations

The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

2000 • 437 citations

The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis

2000 • 403 citations

Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites

1990 • 400 citations

The influence of the microenvironment on the malignant phenotype

2000 • 398 citations

Stomach Cancer Among Japanese in Hawaii<xref ref-type="fn" rid="FN2">2</xref>

1972 • 388 citations

Pieces of the puzzle: expressed sequence tags and the catalog of human genes

1997 • 380 citations

Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays

1999 • 356 citations

Family history and the risk of stomach and colorectal cancer

1992 • 349 citations

E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas

2000 • 349 citations

Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer

1999 • 325 citations

First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial

1997 • 320 citations

E-cadherin gene mutations in human gastric carcinomacell lines.

1994 • 288 citations

c-erbB-2 Is of Independent Prognostic Relevance in Gastric Cancer and Is Associated With the Expression of Tumor-Associated Protease Systems

2000 • 284 citations

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1999 • 279 citations

Expression genetics in cancer: Shifting the focus from DNA to RNA

1997 • 256 citations

A case‐control study of gastric cancer and diet in Italy: II. Association with nutrients

1990 • 240 citations

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

1998 • 234 citations

Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

2000 • 227 citations

Familial occurrence of gastric cancer in the 2-year experience of a population-based registry

1990 • 209 citations

Molecular epidemiology, pathogenesis and prevention of gastric cancer

1999 • 184 citations

Dietary factors and gastric cancer risk. A case-control study in Spain

1993 • 171 citations

Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis

1988 • 170 citations

Cancer risk in the rubber industry: a review of the recent epidemiological evidence.

1998 • 161 citations

DNA microarray technology: the anticipated impact on the study of human disease

1999 • 160 citations

Cancer Mortality and Morbidity Among Rubber Workers<xref ref-type="fn" rid="FN1">2</xref>

1978 • 141 citations

Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Results of intergroup study INT-0116 (SWOG 9008)

2001 • 139 citations

Pathology of Gastric Carcinoma in Japanese Populations: Comparisons Between Miyagi Prefecture, Japan, and Hawaii 2

1973 • 132 citations

Development of adenocarcinomas in the stomach

1986 • 129 citations

Herceptin (trastuzamab) in advanced breast cancer

2000 • 125 citations

Prognostic significance of the number of positive lymph nodes in gastric carcinoma

1994 • 122 citations

Stomach Cancer and Food Storage

1989 • 108 citations

Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma – a population-based study in Sweden

2000 • 102 citations

Germline mutations of E-cadherin gene in Korean familial gastric cancer patients

1999 • 102 citations

Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer.

1993 • 95 citations

Electric refrigerator use and gastric cancer risk

1990 • 79 citations

Prognostic factors in adenocarcinoma of the cardia

1995 • 74 citations

Helicobacter pylori factors associated with disease

1999 • 69 citations

INCIDENCE TRENDS IN OESOPHAGEAL AND PROXIMAL GASTRIC CARCINOMA IN VICTORIA

1996 • 67 citations

Cancer mortality in Europe, 1990-92

1995 • 55 citations

Translational research: walking the bridge between idea and cure--seventeenth Bruce F. Cain Memorial Award lecture.

1998 • 51 citations

Occupational Risk Factors for Gastric Cancer: an Overview

1996 • 50 citations

Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development

1999 • 46 citations

Medical management of advanced gastric cancer

1998 • 43 citations

Chemotherapy for gastric carcinoma: new and old options.

1998 • 39 citations

Making Sense of the Sequence

2001 • 37 citations

Multicritical points in the mixed spin-1 and spin- Ising system on a square lattice with different single-ion anisotropies

2000 • 37 citations

Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.

1981 • 19 citations

The Role of Chemotherapy in the Management of Gastric Cancer

2000 • 16 citations

Heat shock and cytokines modulate the expression of adhesion molecules on different human gastric-cancer cell lines

1996 • 9 citations

Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development

1999 • 6 citations